February 2, 2021

Coverage of Buprenorphine Medications that Treat Opioid Use Disorder by State Medicaid Programs

Buprenorphine is shown to be an effective medication for the treatment of opioid use disorder. It promotes long-term recovery and decreases the risk of mortality. Although Medicaid programs largely cover buprenorphine products, many continue to apply prior authorization (PA) requirements.

This report studies how state Medicaid programs apply PA requirements to buprenorphine products.

View Report

Additional Resources:

Research Center Logo

    Want to stay up to date?

    Sign up for our mailing and never miss a new piece of information.

    I would like updates for:

    Filter Results


    Filter Search Results